Two recent disappointing clinical trials of highly-anticipated weight-loss drugs have made it clear that it is too early to ...

Calorie labels on food may lower calorie intake, but findings on alcohol are inconclusive, indicating a gap in research for ...

Changed eating patterns due to the rising use of anti-obesity drugs originally developed to treat diabetes may benefit red ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to reduce the risks of substance abuse disorders, psychosis, infections, some kinds of cance ...

One of the world’s largest studies of Ozempic, Mounjaro and other blockbuster diabetes and obesity drugs highlighted their impact on the brain, pointing to benefits from addiction to schizophrenia.

While weight-loss drugs were linked to lower risk of some conditions, they were also associated with some adverse health ...

This year, revolutionary anti-obesity drugs Wegovy and Ozempic (manufactured by Danish drugmaker Novo Nordisk), and Eli Lilly ...

Does the natural Mounjaro drink really help with weight loss like the FDA-approved medication? Experts weigh in on the claims ...

Weight-loss drugs have been rolled out by the NHS, but many are buying them through social media and online pharmacies ...

Interestingly, celebrities like Elon Musk, Oprah Winfrey and Amy Schumer, among others, have also endorsed drugs like Ozempic ...

The 15 drugs selected for negotiation are prescribed to 5.3 million Medicare beneficiaries to treat conditions ranging from cancer and type 2 diabetes to asthma.

Obesity medications promise transformative care, but financial and systemic barriers limit access for those most in need.